Soliqua 100/33 Drug Interactions: 2 Major, 641 Moderate
Soliqua 100/33 (Insulin Glargine And Lixisenatide) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Soliqua 100/33. Always confirm against the full prescribing information.
100 interactions
Acarbose
The risk or severity of hypoglycemia can be increased when Acarbose is combined with Insulin glargine.
Level 1 evidence
Acarbose
The risk or severity of hypoglycemia can be increased when Acarbose is combined with Lixisenatide.
Level 2 evidence
Acebutolol
The therapeutic efficacy of Lixisenatide can be increased when used in combination with Acebutolol.
Level 1 evidence
Acebutolol
The therapeutic efficacy of Insulin glargine can be increased when used in combination with Acebutolol.
Level 1 evidence
Acenocoumarol
Lixisenatide can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Acetazolamide
The risk or severity of hypoglycemia can be increased when Acetazolamide is combined with Insulin glargine.
Level 1 evidence
Acetyl sulfisoxazole
The risk or severity of hypoglycemia can be increased when Acetyl sulfisoxazole is combined with Insulin glargine.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Lixisenatide.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin glargine.
Level 1 evidence
Albuterol
The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Salbutamol.
Level 1 evidence
Alclometasone
The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Lixisenatide.
Level 1 evidence
Alclometasone
The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Insulin glargine.
Soliqua 100/33 (Insulin Glargine And Lixisenatide) has 1066 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Soliqua 100/33 (Insulin Glargine And Lixisenatide) has 2 major, 641 moderate, and 423 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Soliqua 100/33. Always confirm against the full prescribing information.